DES design: Theoretical advantages and disadvantages of stent strut materials, design, thickness, and surface characteristics

Journal of Interventional Cardiology

Volumn 22, Issue SUPPL. 1, 2009, Pages

  Bailey, Steven R ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLIMUS A9; CHROMIUM COBALT ALLOY; EVEROLIMUS; IRIDIUM; IRON; MAGNESIUM; METAL; NICKEL; PACLITAXEL; PIMECROLIMUS; PLATINUM; POLYMER; RAPAMYCIN; RAPAMYCIN DERIVATIVE; STAINLESS STEEL; TACROLIMUS; TANTALUM; TITANIUM; UNCLASSIFIED DRUG; ZOTAROLIMUS;

ARTERY INTIMA PROLIFERATION; BIODEGRADABLE IMPLANT; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG ELUTING STENT; DRUG MANUFACTURE; DRUG MECHANISM; MATERIAL COATING; METAL IMPLANTATION; PRIORITY JOURNAL; REVIEW; STENOSIS; SURFACE PROPERTY;

EID: 65649140821     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2009.00449.x     Document Type: Review

References (93)

1. Myler RK, Stertzer SH. Coronary and peripheral angioplasty: Historical perspective. In : Topol EJ, ed., Textbook of Interventional Cardiology. 2nd ed. Philadelphia, PA : W.B. Saunders, 1994, pp. 171 185.
2. Serruys PW, Jaegere PD, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. New Engl J Med 1994 331 : 489 495. (Pubitemid 24256751)
3. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. New Engl J Med 1994 331 : 496 501. (Pubitemid 24256752)
4. Holmes J. State of the art in coronary intervention. Am J Cardiol 2003 91 : 50A 53A. (Pubitemid 36355938)
5. Wolf MG, Moliterno D, Lincoff A, et al. Restenosis: An open file. Clin Cardiol 1996 19 : 347 356. (Pubitemid 26314299)
6. Newby AC, Zaltsman AB. Molecular mechanisms in intimal hyperplasia. J Pathol 2000 190 : 300 309. (Pubitemid 30141376)
7. Kipshidze N, Dangas G, Tsapenko M, et al. Role of the endothelium in modulating neointimal formation: Vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. J Am Coll Cardiol 2004 44 : 733 739. (Pubitemid 39099565)
8. Ong ATL, McFadden EP, Regar E, et al. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J AM Coll Cardiol 2005 45 : 2088 2092. (Pubitemid 40814135)
9. Serruys PW. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005 45 : 2088 2092. (Pubitemid 40814135)
10. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. J Am Med Assoc 2005 293 : 2126 2130. (Pubitemid 40617065)
11. Marroquin OC, Selzer F, Mulukutla SR, et al. A comparison of bare-metal and drug-eluting stents for off-label indications. N Engl J Med 2008 358 : 342 352.
12. Austin D, Oldroyd KG, McConnachie A, et al. Drug-eluting stents versus bare-metal stents for off-label indications: A Propensity Score-Matched Outcome Study. Circ Cardiovasc Intervent 2008 1 : 45 52.
13. Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2007 297 : 159 168. (Pubitemid 46089732)
14. Win HKM, Caldera AE, Maresh K, et al. for the EVENT Registry Investigators. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA 2007 297 : 2001 2009. (Pubitemid 46740352)
15. Schatz RA. A view of vascular stents. Circulation 1989 79 : 445 457. (Pubitemid 19055516)
16. Rundback JH, Leonardo R, Rozenbilt GN. Peripheral vascular stents. In : Dolmatch BL, Blum U, eds. Stent-Grafts Current Clinical Practice. New York : Thieme, 2000, pp. 1 22.
17. Mani G, Feldman MD, Patel D, et al. Coronary stents: A materials perspective. Biomaterials 2007 28 : 1689 1710. (Pubitemid 46080469)
18. Haudrechy P, Foussereau J, Mantout B, et al. Nickel release from 304 and 316 stainless steels in synthetic sweat. Comparison with nickel and nickel-plated metals. Consequences on allergic contact dermatitis. Corros Sci 1993 35 (1-4 329 336.
19. Köster R, Sommerauer M, Kähler J, et al. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet 2000 356 : 1895 1897.
20. Brunski JB. Metals. In : Ratner BD, Hoffman AS, Schoen FJ, Lemons JE, eds. Biomaterials Science: An Introduction to Materials in Medicine, 2nd ed. San Diego, CA : Elsevier Academic Press, 2004, pp. 137 153.
21. Kereiakes D, Cox D, Hermiller J, et al. Usefulness of a cobalt chromium coronary stent alloy. Am J Cardiol 2003 92 : 463 466. (Pubitemid 36959888)
22. Klocke Kemper J, Schulze D, Adam G, et al. Magnetic field Interactions of orthodontic wires during magnetic resonance imaging (MRI) at 1.5 Tesla. J Orofac Orthop 2005 66 : 279 287. (Pubitemid 41131204)
23. Teitelbaum G, Bradley W, Klein B. MR imaging artifacts, ferromagnetism, and magnetic torque of intravascular filters, stents, and coils. Radiology 1988 166 : 657 664. (Pubitemid 18058919)
24. Zitter H, Plenk H. The electrochemical behavior of metallic implant materials as an indicator of their biocompatibility. J Biomed Mater Res 1987 21 : 881 896. (Pubitemid 17112694)
25. Johnson P, Bernstein J, Hunter G, et al. An in vitro and in vivo analysis of anodized tantalum capacitive electrodes: Corrosion response, physiology, and histology. J Biomed Mater Res 1977 11 : 637 656. Macionczyk F, Gerold B, Thull R, Repassivating tantalum/tantalum oxide surface modification on stainless steel implants. Surf Coat Technol 2001;142-144:1084-1087. (Pubitemid 8159584)
26. Chen JY, Leng YX, Zhang X, et al. Effect of tantalum content of titanium oxide film fabricated by magnetron sputtering on the behavior of cultured human umbilical vein endothelial cells. Nucl Instrum Methods Phys Res Sec B: Beam Interact Mater Atoms 2006 242 : 26- 29.
27. Barth K, Virmani R, Froelich J, et al. Paired comparison of vascular wall reactions to Palmaz stents, Strecker tantalum stents, and Wallstents in canine iliac and femoral arteries. Circulation 1996 93 : 2161 2169. (Pubitemid 26187106)
28. Ozaki Y, Keane D, Nobuyoshi M, et al. Coronary lumen at six-month follow-up of a new radiopaque Cordis tantalum stent using quantitative angiography and intracoronary ultrasound. Am J Cardiol 1995 76 : 1103 1212.
29. Davis JR, Metallic Materials, Handbook of Medical Devices. Materials Park, OH : ASM International, 2003, pp. 21 50.
30. Windecker S, Mayer I, Pasquale GD, et al. Stent coating with titanium-nitride-oxide for reduction of neointimal hyperplasia. Circulation 2001 104 : 928 933. (Pubitemid 32778045)
31. Mosseri M, Tamari I, Plich M, et al. Short-and long-term outcomes of the titanium-NO stent registry. Cardiovasc Revasc Med 2005 6 : 2 6. (Pubitemid 41262612)
32. Windecker S, Simon R, Lins M, et al. Randomized comparison of a titanium-nitride-oxide-coated stent with a stainless steel stent for coronary revascularization: The TiNOX trial. Circulation 2005 111 : 2617 2622. (Pubitemid 40740861)
33. Hijazi, Homoud M, Aronovitz M, et al. A new platinum balloon-expandable stent (Angiostent) mounted on a high pressure balloon: Acute and late results in an atherogenic swine model. J Invas Cardiol 1995 7 : 127 134.
34. Bhargava B, Scheerder ID, Ping Q, et al. A novel platinum-iridium, potentially gamma radioactive stent: Evaluation in a porcine model. Cathet Cardiovasc Interv 2000 51 : 364 368.
35. Park JB, Kim YK. Metallic biomaterials. In : Park JB, Bronzino JD, eds. Biomaterials Principles and Applications. Boca Raton, FL : CRC Press, 2003, pp. 1 20.
36. Sumita M, Teoh SH, Durability of metallic implant materials. In : Teoh SH, eds. Engineering Materials for Biomedical Applications. Singapore : World Scientific Publishing, 2004 : 21 31.
37. Stoeckel D, Pelton A, Duerig T. Self-expanding nitinol stents: Material and design considerations. Eur Radiol 2004 14 : 292 301. (Pubitemid 38181087)
38. Trepanier C, Venugopalan R, Pelton AR. Corrosion resistance and biocompatibility of passivated NiTi. In : Yahia LH, ed. Shape Memory Implants. New York : Springer, 2000, pp. 35 45.
39. Maitz M, Shevchenko N. Plasma-immersion ion-implanted nitinol surface with depressed nickel concentration for implants in blood. J Biomed Mater Res A 2006 76 : 356 365.
40. Trepanier C, Tabrizian M, Yahia L, et al. Effect of modification of oxide layer on NiTi stent corrosion resistance. J Biomed Mater Res 1998 43 : 433 440. (Pubitemid 28544103)
41. Mazumder M, De S, Trigwell S, et al. Corrosion resistance of polyurethane-coated nitinol cardiovascular stents. J Biomater Sci Polym Ed 2003 14 : 1351 1362. (Pubitemid 38028748)
42. Shih C, Lin S, Chung K, et al. Increased corrosion resistance of stent materials by converting current surface film of polycrystalline oxide into amorphous oxide. J Biomed Mater Res 2000 52 : 323 332. (Pubitemid 30646802)
43. Nakamura S, Degawa T, Nishida T, et al. Preliminary experience of Act-One™ coronary stent implantation. J Am Coll Cardiol 1996 27 (2, Suppl. 1 53.
44. Holmes DR, Jr., Lansky A, Kuntz R, et al. The PARAGON stent study: A randomized trial of a new martensitic nitinol stent versus the Palmaz-Schatz stent for treatment of complex native coronary arterial lesions. Am J Cardiol 2000 86 : 1073 1079.
45. Isshiki T, Eto K, Ochini M, et al. Nitinol radius stent induces less platelet aggregation than stainless steel PalmazSchatz/ Glanturco-Rubin II stents. J Am Coll Cardiol 1998 31 (Suppl. 1 312.
46. Peuster M, Hesse C, Schloo T, et al. Long-term biocompatibility of a corrodible peripheral iron stent in the porcine descending aorta. Biomaterials 2006 27 : 4955 4962. (Pubitemid 43866928)
47. Mueller PP, May T, Perz A, et al. Control of smooth muscle cell proliferation by ferrous iron. Biomaterials 2006 27 : 2193 2200. (Pubitemid 41774531)
48. Staiger M, Pietak A, Huadmai J, et al. Magnesium and its alloys as orthopedic biomaterials: A review. Biomaterials 2006 27 : 1728 1734. (Pubitemid 41760433)
49. Heublein B, Rohde R, Kaese V, et al. Biocorrosion of magnesium alloys: A new principle in cardiovascular implant technology? Heart 2003 89 : 651 656. (Pubitemid 36606211)
50. Mario CD, Griffiths H, Goktekin O, et al. Drug-eluting bioabsorbable magnesium stent. J Interv Cardiol 2004 17 : 391 395. (Pubitemid 39552594)
51. Eggebrecht H, Rodermann J, Hunold P, et al. Images in cardiovascular medicine. Novel magnetic resonance-compatible coronary stent: The absorbable magnesium-alloy stent. Circulation 2005 112 : e303 e304.
52. Zartner P, Cesnjevar R, Singer H, et al. First successful implantation of a biodegradable metal stent into the left pulmonary artery of a preterm baby. Catheter Cardiovasc Interv 2005 66 : 595 596. (Pubitemid 41779033)
53. Schranz D, Zartner P, Michel-Behnke I, et al. Bioabsorbable metal stents for percutaneous treatment of critical recoarctation of the aorta in a newborn. Catheter Cardiovasc Interv 2006 67 : 671 673.
54. Joseph M, DeSimone MSW. US Patent 20056932930 2005.
55. Tsuji T, Tamai H, Igaki K, et al. Four-year follow-up of the biodegradable stent (IGAKI-TAMAI Stent). Circ J VOL 2004 68 : 1 : 135.
56. Ormiston, JA, Webster MWI, Armstrong G. First-in-human implantation of a fully bioabsorbable drug-eluting stent: The BVS Poly-L-Lactic acid everolimus-eluting coronary stent catheterization and cardiovascular interventions 2007 69 : 128 131.
57. Tanimoto S, Serruys PW, Thuesen L, et al. Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: Insights from the ABSORB and SPIRIT trials. Catheter Cardiovasc Interv 2007 70 (4 515 523. (Pubitemid 47597022)
58. Jabara R, Chronos N, Robinson K. Novel anti-inflammatory salicylate-based bioabsorbable drug-eluting polymeric stent coating. Cardiovascular Revascularization Medicine 2008 9 : 213.
59. Palmaz J. New advances in endovascular technology. Tex Heart Inst J 1997 24 : 156 159. (Pubitemid 27449622)
60. Huang Y, Verbeken E, Schacht E, et al. Local drug delivery using drug-eluting stents. In : Serruys PW, Leon MB, Colombo A, Kutryk MJ, eds. Coronary Lesions: A Pragmatic Approach. London : Martin Dunitz, 2002, pp. 319 335.
61. Pypen C, Plenk H, Ebel M, et al. Characterization of microblasted and reactive ion etched surfaces on the commercially pure metals niobium, tantalum and titanium. J Mater Sci Mater Med 1997 8 : 781 784. (Pubitemid 28005914)
62. Ruckenstein E, Gourisankar SV. A surface energetic criterion of blood compatibility of foreign surfaces. J Colloid Interf Sci 1984 101 : 436 451. (Pubitemid 14668444)
63. Bhat SV. Synthetic polymers. Biomaterials, 2nd ed. Harrow : Alpha Science International, 2005, pp. 64 65.
64. Knetsch M, Aldenhoff Y, Schraven M, et al. Human endothelial cell attachment and proliferation on a novel vascular graft prototype. J Biomed Mater Res A 2004 71 : 615 624. (Pubitemid 39578675)
65. Seeger J, Ingegno M, Bigatan E, et al. Hydrophilic surface modification of metallic endoluminal stents. J Vasc Surg 1995 22 : 327 335.
66. DePalma VA, Baier RE, Ford JW, et al. Investigation of three-surface properties of several metals and their relation to blood compatibility. J Biomed Mater Res 1972 6 : 37 75.
67. Zhao H, Humbeeck JV, Sohier J, et al. Electrochemical polishing of 316L stainless steel slotted tube coronary stents. J Mater Sci Mater Med 2002 13 : 911 916. (Pubitemid 35176955)
68. Hehrlein C, Zimmermann M, Metz J, et al. Influence of surface texture and charge on the biocompatibility of endovascular stents. Coron Artery Dis 1995 6 : 581 586.
69. Palmaz J, Benson A, Sprague E. Influence of surface topography on endothelialization of intravascular metallic material. J Vasc Interv Radiol 1999 10 : 439 444. (Pubitemid 29190251)
70. Vogt P, Sigwart U, Urban P, et al. Immediate and late complications secondary to the implantation of a coronary endoprosthesis, Schweiz Med Wochenschr 1989 119 : 1521 1524. (Pubitemid 19256872)
71. Nebeker JR, Virmani R, Bennet CL, et al. Hypersensitivity cases associated with drug-eluting coronary stents: A review of available cases from the research on adverse drug events and reports (RADAR) project. J Am Coll Cardiol 2006 47 : 182 183. (Pubitemid 43005183)
72. McFadden E, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004 364 : 1466 1467. (Pubitemid 39410418)
73. Virmani R, Kolodgie F, Farb A. Drug-eluting stents: Are they really safe? Am Heart Hosp J 2004 2 : 85 88.
74. Bar F, Veen FVD, Benzina A. New biocompatible polymer surface coating for stents results in a low neointimal response. J Biomed Mater Res 2000 52 : 193 198. (Pubitemid 30490997)
75. Banai S, Gertz S, Gavish L, et al. Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries. Cardiovasc Res 2004 64 : 165 171. (Pubitemid 39208933)
76. Van Der Giessen WJ, Lincoff AM, Schwartz RS, et al. Marked inflammatory sequelae toimplantation of biodegradable and nonbiodegradablel polymers in porcinecoronary arteries. Circulation 1996 94 : 1690 1697. (Pubitemid 26320276)
77. Tamai H, Gaki K, Kyo E, et al. Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation 2000 102 : 399 404. (Pubitemid 30490677)
78. Valimaa, Laaksovirta S. Degradation behavior of self-reinforced 80L/20G PLGA devices in vitro. Biomaterials 2004 25 : 1225 1232. (Pubitemid 37476200)
79. Zilberman M, Schwade ND, Eberhart RC. Protein-loaded bioresorbable fibers and expandable stents: Mechanical properties and protein release. J Biomed Mater Res Part B Appl Biomater 2004 69B : 1 10. (Pubitemid 38391992)
80. Lewis A, Stratford P. Phosphorylcholine-coated stents. J Long Term Eff Med Implants 2002 12 : 231 250. (Pubitemid 36232469)
81. Meredith IT. RESOLUTE: Four-month angiographic and IVUS subset. Presented at: Transcatheter Cardiovascular Therapeutics Symposium October 22-27, Washington, DC, 2006.
82. Aoki J, Serruys PW. van Beusekom H, et al. Endothelial progenitor cell capture by stents coated with antibody against CD34: The HEALING-FIM (Healthy endothelial accelerated lining inhibits neointimal growth-first in man) Registry. J AmColl Cardiol. 2005 45 : 1574 1579. (Pubitemid 40704488)
83. Mani G, Dave M, Johnson DM, et al. Drug delivery from gold and titanium surfaces using self-assembled monolayers. Biomaterials 2008 29 : 4561 4573.
84. Briguori C, Sarais C, Pagnotta P, et al. In-stent restenosis in small coronary arteries: Impact of strut thickness. J Am Coll Cardiol 2002 40 : 403 409.
85. Ortolani P, Marzocchi A, Marrozzini C, et al. Randomized comparative trial of a thin-strut bare metal cobalt chromium stent versus a sirolimus-eluting stent for coronary revascularization. Catheter Cardiovasc Interv 2007 69 : 799 800. (Pubitemid 46867478)
86. Pache J, Kastrati A, Mehilli J, et al. Intracoronary stenting and angiographic results: Strut thickness effect on restenosis outcome (ISARSTEREO-2) trial. J Am Coll Cardiol 2003 41 : 1283 1288. (Pubitemid 36438988)
87. LaDisa JF, Olson LE, Douglas HA, et al. Alterations in regional vascular geometry produced by theoretical stent implantation influence distributions of wall shear stress: Analysis of a curved coronary artery using 3D computational fluid dynamics modeling. BioMedical Engineering OnLine 2006 5 : 40. (Pubitemid 44251339)
88. LaDisa Olson LE, Douglas HA, Warltier DC, et al. Axial stent strut angle influences wall shear stress after stent implantation: Analysis using 3D computational fluid dynamics models of stent foreshortening. Am J Physiol Heart Circ Physiol 2005 288 : 2465 2475.
89. Cervera JJB. Stent design and arterial mechanics: Parameterization tools using the finite element method. Handle.TAMU.EDU 2006.
90. Gijsen FJ, Francesco Migliavacca F, Schievano S, et al. Simulation of stent deployment in a realistic human coronary artery. BioMedical Engineering OnLine 2008 7 : 1 11.
91. Gingras AC, Raught B, Sonenberg N. mTOR signaling to translation. Curr Top Microbiol Immunol 2004 279 : 169 197. (Pubitemid 37047263)
92. Abal, Andreu JM, Barasoain I. Taxanes: Microtubule and centrosome targets, and cell cycle dependent mechanisims of action. Curr Cancer Drug Targets 2003 3 : 193 203. (Pubitemid 36565761)
93. Daemen J, Serruys PW. Drug-eluting stent update 2007 part I: A survey of current and future generation drug-eluting stents: Meaningful advances or more of the same? Circulation 2007 116 : 316 328. (Pubitemid 47196568)